Gemigliptin Tartarate
$300.00
CAS No.: 911637-19-9
Catalog No.: LT0137
Purity: 95%
MF: C18H19F8N5O2
MW: 489.367
Storage: 2-8 degree Celsius
SMILES: N[C@H](CN1C(CCC(C1)(F)F)=O)CC(=O)N1CC=2N=C(N=C(C2CC1)C(F)(F)F)C(F)(F)F
Catalog No.: LT0137
Purity: 95%
MF: C18H19F8N5O2
MW: 489.367
Storage: 2-8 degree Celsius
SMILES: N[C@H](CN1C(CCC(C1)(F)F)=O)CC(=O)N1CC=2N=C(N=C(C2CC1)C(F)(F)F)C(F)(F)F
CAS No.: 911637-19-9; Gemigliptin Tartarate. PROPERTIES: Gemigliptin Tartarate is a dipeptidyl peptidase-4 inhibitor with molecular formula C28H33N5O8. This white crystalline solid has a molecular weight of approximately 563.6 g/mol. It exhibits excellent solubility in aqueous solutions at physiological pH. The compound is stable under normal laboratory conditions but should be stored at room temperature in sealed containers. Safety precautions include wearing splash goggles and avoiding skin contact. Gemigliptin Tartarate is classified as a Category 4 drug hazard. APPLICATIONS: In metabolic syndrome research, Gemigliptin Tartarate serves as a model compound for studying DPP-4 inhibition in glucose regulation, as documented in Journal of Pharmacology and Experimental Therapeutics. Its application in developing combination therapies for type 2 diabetes is reported in Diabetes Technology & Therapeutics. In clinical pharmacology, the reagent enables assessment of drug-drug interactions through CYP enzyme inhibition studies, with findings published in Clinical Pharmacology & Therapeutics. Additionally, it has applications in investigating renal handling of DPP-4 inhibitors, as described in Kidney International.
Reviews
Write Your Own Review